Skip to main content

Table 3 The result of cost-effectiveness analysis

From: The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran

Strategy

Cost (USD)

QALYs

\(\Delta \mathrm{ C}\)

\(\Delta \mathrm{ QALYs}\)

BNP vs. Standard clinical assessment

BNP

1835

2.18

− 541

0.11

Dominant

Standard clinical assessment

2376

2.07

  
  1. QALYs, quality-adjusted life years; \(\Delta \mathrm{ C}\), cost difference; \(\Delta \mathrm{ QALYs}\), QALY difference
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us